USA flag logo/image

An Official Website of the United States Government

Screening for anti-RSV compounds with indicator cells

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
65880
Program Year/Program:
2003 / SBIR
Agency Tracking Number:
AI047552
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
APATH, LLC
APATH, LLC 893 N. WARSON RD. SAINT LOUIS, MO 63141
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2003
Title: Screening for anti-RSV compounds with indicator cells
Agency: HHS
Contract: 2R44AI047552-02A1
Award Amount: $0.00
 

Abstract:

DESCRIPTION (provided by applicant): The goal of this project is to use an infection-independent cell-based assay to identify compounds that inhibit respiratory syncytial virus (RSV). The basis of this bioassay is expression of a reporter gene from an artificial viral genome present within the cytoplasm of transfected cells. Significant advances have been made in identifying the cis-acting elements and trans-acting factors involved in replication of many pathogenic negative-strand RNA viruses including RSV. Negative-strand RNA viruses include some of the most notorious human pathogens and cause significant worldwide morbidity and mortality due to severe respiratory disease and hemorrhagic fever syndromes. Unfortunately very few therapeutic agents are available to treat infection with these viruses. Efforts to find new antiviral agents will require methods that are amenable to HTS. In this application the investigators describe their plans to use novel cell-based assays to identify compounds with anti-RSV activity. To identify 'hits' that inhibit replication of RSV the applicants plan to screen a unique library of natural compounds and several novel libraries of synthetic compounds. Apath's partner has developed a proprietary system for making compound libraries from plant-based material. High abundance compounds that lack drug like properties are removed, and the remaining compounds are chromatographically fractionated into distinct peaks, which are provided to Apath, LLC as arrays in bar-coded 96-well plates. Synthetic chemical libraries have been obtained from commercial sources that use novel approaches to make diverse compounds from well-conceived scaffolds. Antiviral activity of all 'hits' will be confirmed in secondary assays to measure inhibition of RSV directly. The investigators will identify compounds with the most promising chemical and biological profiles to pursue as potential anti-RSV drugs. The applicants also plan to identify the targets of the inhibitory compounds through biochemical and genetic approaches.

Principal Investigator:

Paul D. Olivo
3148128144
OLIVO@APATH.COM

Business Contact:

L. Milton
3148128160
MILTON@APATH.COM
Small Business Information at Submission:

APATH, LLC
893 N. WARSON RD. ST. LOUIS, MO 63141

EIN/Tax ID: 431828778
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No